PuSH - Publikationsserver des Helmholtz Zentrums München

Lal, D.* ; Ruppert, A.K.* ; Trucks, H.* ; Schulz, H.* ; de Kovel, C.G.F.* ; Kasteleijn-Nolst Trenité, D.* ; Sonsma, A.C.* ; Koeleman, B.P.* ; Lindhout, D.* ; Weber, Y.G.* ; Lerche, H.* ; Kapser, C.* ; Schankin, C.J.* ; Kunz, W.S.* ; Surges, R.* ; Elger, C.E.* ; Gaus, V.* ; Schmitz, B.* ; Helbig, I.* ; Muhle, H.* ; Stephani, U.* ; Klein, K.M.* ; Rosenow, F.* ; Neubauer, B.A.* ; Reinthaler, E.M.* ; Zimprich, F.* ; Feucht, M.* ; Møller, R.S.* ; Hjalgrim, H.* ; de Jonghe, P.* ; Suls, A.* ; Lieb, W.* ; Franke, A.* ; Strauch, K. ; Gieger, C. ; Schurmann, C.* ; Schminke, U.* ; Nürnberg, P.* ; Sander, T.*

Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies.

PLoS Genet. 11:e1005226 (2015)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Genetic generalised epilepsy (GGE) is the most common form of genetic epilepsy, accounting for 20% of all epilepsies. Genomic copy number variations (CNVs) constitute important genetic risk factors of common GGE syndromes. In our present genome-wide burden analysis, large (≥ 400 kb) and rare (< 1%) autosomal microdeletions with high calling confidence (≥ 200 markers) were assessed by the Affymetrix SNP 6.0 array in European case-control cohorts of 1,366 GGE patients and 5,234 ancestry-matched controls. We aimed to: 1) assess the microdeletion burden in common GGE syndromes, 2) estimate the relative contribution of recurrent microdeletions at genomic rearrangement hotspots and non-recurrent microdeletions, and 3) identify potential candidate genes for GGE. We found a significant excess of microdeletions in 7.3% of GGE patients compared to 4.0% in controls (P = 1.8 x 10-7; OR = 1.9). Recurrent microdeletions at seven known genomic hotspots accounted for 36.9% of all microdeletions identified in the GGE cohort and showed a 7.5-fold increased burden (P = 2.6 x 10-17) relative to controls. Microdeletions affecting either a gene previously implicated in neurodevelopmental disorders (P = 8.0 x 10-18, OR = 4.6) or an evolutionarily conserved brain-expressed gene related to autism spectrum disorder (P = 1.3 x 10-12, OR = 4.1) were significantly enriched in the GGE patients. Microdeletions found only in GGE patients harboured a high proportion of genes previously associated with epilepsy and neuropsychiatric disorders (NRXN1, RBFOX1, PCDH7, KCNA2, EPM2A, RORB, PLCB1). Our results demonstrate that the significantly increased burden of large and rare microdeletions in GGE patients is largely confined to recurrent hotspot microdeletions and microdeletions affecting neurodevelopmental genes, suggesting a strong impact of fundamental neurodevelopmental processes in the pathogenesis of common GGE syndromes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.528
1.709
60
60
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Autism Spectrum Disorder; Copy Number Variants; Genome-wide Association; Of-function Mutations; Epileptic Encephalopathy; Developmental Delay; Intellectual Disability; 15q13.3 Microdeletions; 16p13.11 Predispose; Common Epilepsies
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 1553-7390
e-ISSN 1553-7404
Zeitschrift PLoS Genetics
Quellenangaben Band: 11, Heft: 5, Seiten: , Artikelnummer: e1005226 Supplement: ,
Verlag Public Library of Science (PLoS)
Verlagsort San Francisco
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Genetic Epidemiology (IGE)
Institute of Epidemiology (EPI)
POF Topic(s) 30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504100-001
G-504091-004
PubMed ID 25950944
Scopus ID 84975810789
Erfassungsdatum 2015-05-09